Try our Advanced Search for more refined results
Life Sciences - January, 2011
150 articles
- Judge Sanctions Roxane In Asacol Patent Suit
- False Patent Marking Defendants Gear Up For Round 2
- Judge Nixes Bayer Patent Suit Over Centocor's Simponi
- GSK Settles Wrongful Death Suit In Avandia MDL
- Genzyme, Sanofi Make Progress Toward Takeover Deal
- Novartis Sues Biogen, Others Over Gene Sequencing IP
- J&J Slammed With $482M Verdict In Stent Patent Suit
- Newly Bankrupt Angiotech Ends Merger Fight For $6M
- Novartis' Lescol Patent Enforceable, Judge Says
- ReNeuron To Pay Neuralstem To End Stem Cell Row
- Fed. Circ. Keeps Tyco Appeal Alive In Restoril Row
- US Sues Guidant Over Defective Defibrillators
- Baxter Hit With FDA Warning Over Puerto Rico Plants
- NY AG's Office Beefs Up Fraud-Fighting Units
- Dutch Court Nixes GSK Asthma Drug Patent
- Microsoft Asks High Court To Ease Patent Invalidation
- FDA Eyes AngioDynamics Over Surgical Knife Marketing
- HGS Sues Genentech To Protect Lupus Drug
- Roche Hit With Suit Over Blood Typing Patent
- Warner Chilcott, Roche Sue Teva Over Actonel ANDA
- AstraZeneca To Pay $20.5M In Ky. Medicaid Fraud Suit
- Fed. Circ. Trims Medtronic Surgery Patent Claims
- Pfizer Sanctioned Over Shoddy Witness Testimony
- FDA Suspects Link Between Breast Implants, Cancer
- FDA Set To Bump Defibrillators Up In Risk Class
- Kohl Resurrects 3 Antitrust Bills For New Congress
- Omnicare V. UnitedHealth: Premerger Best Practices
- Ortho Beats Watson Defenses In Birth Control IP Spat
- DOJ Eyes Defibrillators In Medicare Overbilling Probe
- 5th Circ. Affirms Dismissal Of Stryker Prosthetic Suit
- US To Weigh In On Legality Of False Marking Statute
- Merrill Lynch Settles SEC Fraud Charges For $10M
- NY Assembly Committee Advances E-Cigarette Ban
- AGs Ask 8th Circ. To Revive Drug Monopoly Suit
- Mylan Settles Suits Over Pfizer's Lipitor, Caduet
- 5 Ways To Draft Bulletproof Patent Claims
- Sullivan & Cromwell Reps Amgen In $1B BioVex Deal
- Mylan Faces Patent Suit Over Generic Comtan
- Protected Docs Still In Play In Generic Asacol Spat
- US Won $2.5B In Health Care Fraud Cases In '10: Study
- DC Circ. Won't Revisit Decision On E-Cigarettes
- Cravath Advises Novartis In $470M Genoptix Deal
- 9th Circ. Rules On Preemption In Generics Case
- Cialis Patent Suit Won't Go Before Supreme Court
- DOJ Ends J&J Blood Reagent Price-Fixing Probe
- Allergan Investor Suit Over Botox Deal Put On Hold
- Pfizer Silences Testimony On Short-Term Prempro Use
- Walgreens Ducks Fraud Action Over Pills In 7th Circ.
- Ex-Lehman Execs Want Savings Plan Action Tossed
- Fresenius Sues Zydus Over Generic PhosLo GelCaps
- St. Jude To Pay $16M To Settle FCA Suit
- Lilly Targets Pharma Cos. In Gemzar ITC Suit
- King Sues Intelliject Over EpiPen Patent Violation
- Funds Frozen In Seattle Genetics Insider Trading Case
- United, Merck Hit With Navy Communications IP Suits
- Bard Scores Partial Win In Covidien Patent Fight
- Celgene Ordered To Turn Over Thalomid Price Data
- Pfizer Sued Over Termination Of Wyeth Patent Pact
- Trumpf Wins Refund Of Surgical Lamp Duties
- Morgan Lewis Reps Perrigo In $540M Paddock Labs Buy
- Supreme Court Mulls Medicaid Clinics' Rights To Sue
- FDA Unveils Changes To Medical Device Review Process
- J&J Escapes Toxic Baby Shampoo Action
- Genetics Co. Sues 6 Labs Over DNA Test Patent
- 8th Circ. Revives Class Action Over KV Recalls
- Judge Finds Novo's Prandin Patent Invalid
- J&J Unit Recalls 43M Bottles Made In Pa. Plant
- Boston Scientific To Pay Up To $375M For Atritech
- Drug Cos. Try To Keep Cephalon Case Info Under Wraps
- Judge Sets Stage For Trial In Norvir Monopoly Case
- Supreme Court Weighs Class Rules In Baycol Case
- Mylan, Ethypharm Strike Deal In FazaClo Patent Spat
- $76M Mylan Suit Remanded Over Jurisdictional Issues
- GSK To Pay £2.2B Legal Bill For Avandia Suits
- High Court Won't Hear Apotex's Exclusivity Appeal
- Ex-Stryker Exec Tries To Nix Cover-Up Claim
- High Court To Hear Fight Over Calif. Medicaid Cuts
- Ciba, J&J End Acuvue Patent Row In Fed. Circ.
- Case Study: Matrixx Initiatives Inc. V. Siracusano
- EU Seeks Info On Drug Patent Deals From 2010
- Abbott Scores $16M Win In Suit Over Generic Tarka
- Sanofi Beats Back Apotex Generic In Uroxatral MDL
- Bankruptcy Appeals Court Says Qualia Can Avoid Liens
- FDA Urged To Boost Oversight Of Food Safety Claims
- Venable Lures FDA Regulatory Expert To DC Outpost
- Blue Shield Offers Up Calif. Rates For Review
- Watson, Teva Clash Over Seasonique In Fed. Circ.
- Sanofi Heart Drug Multaq Linked To Liver Failure
- Case Study: Microsoft Corp. V. I4i LP
- Judge OKs $4.75M Quigley Deal Over Asbestos Claims
- Shire Sues Alkem Over Fosrenol Patents
- Bayer Sues Sun Pharmaceutical Over Yaz Patents
- Trial Patient Sues Abbott Over Humira Cancer Risks
- Aventis Sues Sandoz Over Generic Taxotere
- FDA Limits Acetaminophen Use In Prescription Drugs
- Allergan Sues Sandoz Over Sanctura XR Patents
- Spire Sues Creganna Unit Over Catheter Flaws
- Ore. AG Says Phantom Recall Misled Consumers
- Ad Groups Fired Up Over Graphic Cigarette Labels
- Guidant To Pay $296M Penalty In Defibrillator Case
- Fen-Phen Lawyer Indicted For Insurance Fraud
- TriMed Resolves Stryker Suit Over Wrist Repair IP
- NPEs Reap Big Rewards In IP Actions: Study
- Novo Seeks To Toss Antitrust Claims in Prandin Suit
- Merck Unit EMD Faces False Patent Marking Suit
- Apotex Sues Forest Labs Over Generic Lexapro
- Sobering Developments In Health Care Exclusion
- Justices Mull Drug Disclosures In Matrixx Fraud Case
- CVS To Pay $1M To Bury Banned Pharmacist Case
- Ex-InterMune CEO Says Withheld Docs Clear His Name
- 7th Circ. Upholds Omnicare Antitrust Suit Dismissal
- Boston Scientific Bags $104M IP Arbitration Deal
- Post Ariad: Written Descriptions For Patents
- Judge Voids PDL Antibody Patent In MedImmune Suit
- US Backs Drugmakers In Supreme Court Pricing Suit
- AGs Push High Court To Hear Pay-For-Delay Drug Suit
- Amgen Wins Ban On Teva's Generic Version Of Sensipar
- FDA Aims To Bolster Industry Transparency
- Aurobindo, Wyeth Settle Fight Over Generic Effexor
- Judge Stands By $21M Jury Verdict In Sulindac Case
- Lilly, Xanodyne Hid Darvocet Risks, Suit Says
- Sanofi Targets Accord Over Generic Taxotere
- Navinta Faces New Suit Over Generic Naropin ANDA
- AAI Asks 8th Circ. To Revive FTC Drug Monopoly Suit
- House Advances Health Care Repeal Vote
- FDA Doesn't Have To Release Provenge Docs: 2nd Circ.
- Jenner & Block Snags Goodwin M&A Expert
- Judge Shuts Door On Medtronic ERISA Action
- SEC Backs Off Indicted Richards Layton IT Guy For Now
- First Lady Taps Former Skadden Atty As Chief Of Staff
- Shareholders Join Suits In XenoPort Stock Price Case
- HHS Warns Of Health Care Repeal Dangers
- Nycomed Calls On WilmerHale In Vanos Patent Suit
- Novartis Loses Bid To Toss $2.6M Zometa Award
- Supreme Court Patent Cases: Past And Pending
- GSK Loses Bid To Bar Testimony On Avandia Risks
- FDA Warns Invacare Over Electric Bed Fire Hazards
- FDA Tackles Food Safety As Funding Remains Uncertain
- Portuguese Court Upholds €3M Abbott Price-Fixing Fine
- False Marking Suit Survives Ranbaxy's Dismissal Bid
- IP Cases To Watch In 2011
- A 'Storm Warning' For The Reinsurance Industry
- FDA Deputy Commissioner To Resign For Md. Job
- PharmAthene, SIGA Fight Over Bioterror Defense Drug
- Mylan To Pay $65M To Bury Medicaid Inflation Claims
- Paul Weiss Reps Universal In $1.25B CVS Deal
- FTC Challenges Lundbeck Drug Monopoly In 8th Circ.
- Latency Periods And The Statute Of Limitations
- Lupin Strikes Deal In Suit Over Generic Lunesta
- Wyeth Hit With $1.5M Verdict In Prempro Case